ArticleFrontiers in pharmacology2026

CRIP1 promotes docetaxel resistance and immune-associated cell death modulation in prostate cancer.

Dehua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.